Special Issue "Advancements in Minimally Invasive Urologic Surgery"
Deadline for manuscript submissions: closed (24 September 2023) | Viewed by 4265
Interests: reconstructive urology; urethral stricture disease; uro-oncology; prostate cancer; bladder cancer; benign prostate hyperplasia; minimal invasive surgical treatments
Since it first emerged, urology has been a main driver of surgical innovations and technological developments, e.g., transurethral procedures for benign prostate hyperplasia and stone treatment, as well as robotic surgery or focal therapy.
As a minimally invasive treatment of benign prostate hyperplasia, laser-based surgery has pretty much become the new gold standard and entered into all guidelines. The use of new-generation pulsed thulium lasers or MOSES technology represents the latest development in the field, and they seem to outperform previous energy sources. Other surgical options such as water-based treatments (Rezum, Aquablation) and further minimally invasive procedures such as prostate artery embolization, iTIND or UroLift are also entering the market.
In uro-oncology, robotic surgery represents the latest development with new systems and operative access methods and is already a well-established tool for treating prostate and kidney cancer. However, for radical cystectomy, robotic surgery is only just about to gain widespread acceptance and is currently being investigated in ongoing studies.
All these approaches have the same goal of improving patients’ quality of life, shortening hospital stays, and reducing complication rates.
This Special Issue aims to provide an overview of the latest advancements in minimally invasive urologic surgery. We investigate not only future directions but also potential dead ends and meanders of this fascinating journey.
Dr. Clemens M. Rosenbaum
Dr. Benedikt Becker
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- minimally invasive surgical treatments
- benign prostate hyperplasia
- robotic surgery
- urinary stone disease
- focal therapy
- laparoscopic surgery